Current FY Submissions

The following are a list of recent fiscal year grant submissions the Center for Women's Health Research. Learn more about our services and obtain assistance with your own submission.

FY2015

July 1, 2014 through June 30, 2015

Improving Women's Sexual Health While in Drug Addiction Treatment

Hendree Jones, PhD; Director, UNC Horizons
R34 Submission
Sponsor: NIH National Institute on Drug Abuse (NIDA)
Submitted: July 15, 2014

 

The UNZA Centre for Women's Health Research

Ben Chi, MD; Division of Women's Global Health
D43 Subgrant
Sponsor: National Institutes of Health (NIH)
Submitted: July 17, 2014

 

Progestin Contraception and HIV Risk: A randomized trial in Malawi

Charles Van Der Horst, MD; Associate Chief, Division of Infectious Diseases
R01 Submission
Sponsor: National Institutes of Health (NIH)
Submitted: September 8, 2014

 

Increasing Buprenorphine Acceptance and Retention in Treatment Seeking Pregnant Women with Severe Opioid Use Disorder

Hendree Jones, PhD; Director of UNC Horizons
R01 Submission
Sponsor: Johns Hopkins University
Submitted: September 10, 2014

 

Antihypertensive Therapy for Mild Chronic Hypertension during Pregnancy A Pragmatic Multicenter Randomized Trial CHAP Project

Kim Boggess, MD; Division of Maternal Fetal Medicine
R01 Subcontract Submission
Sponsor: University of Alabama at Birmingham
Submitted: September 25, 2014

 

Lipoxins Resolvins and Endometriosis

Steve Young. MD, PhD: Division of Reproductive Endocrinology and Infertility
R01 Submission
Sponsor: National Institutes of Health (NIH)
Submitted: September 29, 2014

 

Birth Control HIV Risk Reduction Among Women Who Inject Drugs

Hendree Jones, PhD; Director of UNC Horizons
R34 Submission
Sponsor: National Institutes of Health (NIH)
Submitted: October 7, 2014

 

Genetics and Epidemiology of Placental Abruption

Alison Stuebe, MD; Division of Maternal Fetal Medicine
R01 ReSub, Subcontract to Columbia
Sponsor: National Institutes of Health (NIH)
Submitted: October 24, 2014

 

Biomarkers of High-Grade Cervical Dysplasia

Lisa Rahangdale, MD, MPH; Division of Women's Primary Healthcare
R01 Resubmission
Sponsor: National Institutes of Health (NIH)
Submitted: November 5, 2014

 

Effect of Nicotinamid (Vitamin B3-Amide) Supplement to Early Onset Preeclampsia

Kim Boggess, MD; Division of Maternal Fetal Medicine
R21 Resubmission
Sponsor: National Institute of Child Health and Human Development (NICHD)
Submitted: November 14, 2014

 

NC PLUS: UNC-CH Bladder Health Clinical Center

Jennifer Wu, MD, MPH; Division of Urogynecology and Reconstructive Pelvic Surgery
U01 Submission
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Submitted: November 20, 2014

 

Sex Hormones and Hepatobiliary Disposition in Pregnancy

Craig Lee, PharmD, PhD; Pharmacotherapy and Experimental Therapeutics
U54 Sucontract to Duke University
Sponsor:
Submitted: November 21, 2014

 

NCC Obstetric-Fetal Pharmacology Research Center (OPRC)

Kim Boggess, MD; Division of Maternal Fetal Medicine
U54 Subcontract to Duke University
Sponsor: National Institutes of Health (NIH)
Submitted: November 25, 2014

 

UNC BIRCWH - Building Interdisciplinary Research Careers in Women's Health

Kim Boggess, MD; Division of Maternal Fetal Medicine
K12 Submission
Sponsor: National Institutes of Health (NIH)
Submitted: January 5, 2015

 

A Trial of 17-Hydroxyprogesterone Caproate (17P) to Reduce Preterm Birth Among Women Receiving Antiretroviral Therapy in Pregnancy

Jeff Stringer, MD; UNC Global Women's Health
R01 Submission
Sponsor: National Institutes of Health (NIH)
Submitted: January 7, 2015

 

Antidepressant Pharmacotherapy to Improve Adherence, Retention, and Other HIV Outcomes Among Postpartum Women with Depression and Their Children: a Randomized Trial in Lusaka, Zambia

Elizabeth Stringer, MD; Division of Maternal-Fetal Medicine
R01 Submission
Sponsor: National Institutes of Health (NIH)
Submitted: January 7, 2015

 

Mentoring new investigators in PMTCT implementation research

Benjamin Chi, MD; UNC Global Women's Health
K24 Submission
Sponsor: National Institutes of Health (NIH)
Submitted: January 7, 2015

 

Increasing interpregnancy intervals through systematic improvement of postpartum contraceptive care

Gretchen Stuart, MD, MPH; Division of Women's Primary Healthcare
R01 Sub to UChicago
Sponsor: National Institutes of Health (NIH)
Submitted: January 7, 2015

 

High-Risk Human Papilloma Virus and Preeclampsia: A Nested Case-Control Study

Lisa Rahangdale, MD, MPH; Division of Women's Primary Healthcare
R01 Subcontract to Columbia
Sponsor: National Institutes of Health (NIH)
Submitted: January 21, 2015

 

Evidence Based and Cost-Effective Implementation Strategies for Scaling-up Cervical Cancer Prevention in Sub-Saharan Africa

Groesbeck Parham, MD; UNC Global Women's Health
R01 Subcontract to RTI
Sponsor: National Institutes of Health (NIH)
Submitted: January 28, 2015

 

Gold nanosensor for early detection of colorectal cancer in low and middle income countries

Groesbeck Parham, MD; UNC Global Women's Health
UH2 Resubmission, Subcontract to UMissouri
Sponsor: National Institutes of Health (NIH)
Submitted: January 28, 2015

 

Medical optimization & management of pregnancies with overt type 2 diabetes (MOMPOD)

Kim Boggess, MD; Division of Maternal Fetal Medicine
R01 Submission
Sponsor: National Institutes of Health (NIH)
Submitted: February 4, 2015

 

High-Risk Human Papilloma Virus and Preeclampsia: A Nested Case-Control Study

Lisa Rahangdale, MD, MPH; Division of Women's Primary Healthcare
R01 Subcontract Resubmission
Sponsor: Columbia University
Submitted: February 13, 2015

 

Gold nanosensor for early detection of colorectal cancer in low and middle income countries

Groesbeck Parham, MD; UNC Global Women’s Health
UH2 Subcontract Resubmission
Sponsor: University of Missouri
Submitted: February 20, 2015

 

The VIA-Liger Study

Groesbeck Parham, MD; UNC Global Women’s Health
UH2 Subcontract Submission
Sponsor: IARC
Submitted: March 2, 2015

 

Cancer Detection, Diagnosis, and Treatment Technologies for Global Health

Groesbeck Parham, MD; UNC Global Women’s Health
UH2 Subcontract
Sponsor: Purdue University
Submitted: March 3, 2015

 

Embryo-Uterine Cross-Talk during Implantation and Establishment of Pregnancy

Steve Young, MD, PhD: Division of Reproductive Endocrinology and Infertility
P01 Subcontract
Sponsor: University of Illinois
Submitted: April 29, 2015

 

Pregnancy Eating Attributes Study (PEAS) fMRI Substudy

Kyle Burger, PhD: Department of Nutrition
Supplemental Budget
Sponsor: NICHD
Submitted: April 30, 2015

 

Center of Excellence (CoE) on Behavioral Health for Pregnant and Postpartum Women (PPW) and their Families

Hendree Jones, PhD; Director of UNC Horizons
Subcontract Submission
Sponsor: UMKC (SAMHSA Prime)
Submitted: May 1, 2015

 

Mentoring new investigators in PMTCT implementation research

Ben Chi, MD; UNC Global Women's Health
K24 Resubmission
Sponsor: National Institutes of Health (NIH)
Submitted: May 7, 2015

 

A Randomized Trial of 17-Hydroxyprogesterone Caproate (17P) to Reduce Preterm Birth Among Women Receiving Antiretroviral Therapy in Pregnancy

Jeff Stringer, MD; UNC Global Women's Health
R01 Submission
Sponsor: National Institutes of Health (NIH)
Submitted: May 7, 2015

 

Genetics and Epidemiology of Placental Abruption

Alison Stuebe, MD; Division of Maternal Fetal Medicine
R01 Subcontract Submission
Sponsor: Columbia University
Submitted: May 18, 2015

 


FY2014

(July 1, 2013 through June 30, 2014)

Lactation, oxytocin and maternal cardiometabolic health later in life

Alison Stuebe. MD: Division of Maternal Fetal Medicine
Subcontract to UTMB
Sponsor: American Heart Association
Submitted: July 10, 2013

 

Role of oxytocin and lactation in long-term maternal cardiometabolic health

Alison Stuebe. MD: Division of Maternal Fetal Medicine
Subcontract to UTMB
Sponsor: American Heart Association
Submitted: July 10, 2013

 

Pathiophysiology of Endometriosis and Adenomyosis

Steve Young. MD, PhD: Division of Reproductive Endocrinology and Infertility
U54 Subcontract to Michigan State
Sponsor: NICHD
Submitted: July 12, 2013

 

An mHealth approach to improving care to UNC OB/GYN patients: Evaluating user engagements, care patterns, and values offered to providers

John Thorp, Jr. MD: Division of Women's Primary Healthcare
Subcontract to Keona Health
Sponsor: NIH
Submitted: July 30, 2013

 

Determination of Fetal Gene Expression in Women with Preterm and Term Birth

Neeta Vora, MD : Division of Maternal Fetal Medicine
RO3 Submission
Sponsor: NIH
Submitted: October 2, 2013

 

Estimating population coverage of 17- hydroxyprogesterone to prevent preterm birth

Elizabeth Stringer, MD : Division of Maternal Fetal Medicine
RO3 Submission
Sponsor: NIH
Submitted: November 7, 2013

 

Comparing Options for Management: Patient-Centered Results in Uterine Fibroids (COMPARE-UF)

Wanda Nicholson, MD, MPH, MBA : Division of Women's Primary Healthcare
P50 Subcontract to Duke
Sponsor: AHRQ
Submitted: November 22, 2013

 

Comparing methods for identifying the best options for individual patients, and for improving quality-of-care

Wanda Nicholson, MD, MPH, MBA : Division of Women's Primary Healthcare
P50 Subcontract to Duke
Sponsor: AHRQ
Submitted: December 4, 2013

 

Biomarkers of High-Grade Cervical Dysplasia

Lisa Rahangdale, MD, MPH : Division of Women's Primary Healthcare
RO1 Submission
Sponsor: NIH
Submitted: January 21, 2014

 

High-Risk Human Papilloma Virus and Preeclampsia: A Nested Case-Control Study

Lisa Rahangdale, MD, MPH : Division of Women's Primary Healthcare
R01 Subcontract to Columbia
Sponsor: NIH
Submitted: January 21, 2014

 

Diminished Ovarian Reserve: Identification of Genetic Risk Factors

Steve Young. MD, PhD: Division of Reproductive Endocrinology and Infertility
R01 Subcontract to UVA
Sponsor: NIH
Submitted: January 23, 2014

 

A retrospective survey of preterm patients with preeclampsia who were hospitalized at potential clinical trial sites over the previous two years to establish feasibility for the PRESERVE-1 study

John Thorp, Jr. MD: Division of Women's Primary Healthcare
Clinical Trial
Sponsor: rEVO Biologics, Inc
Submitted: February 21, 2014

 

Xenform Postmarket Surveillance Study: Xenform A Prospective, Non-Randomized, Parallel Cohort, Multi-Center Study of Xenform vs. Native Tissue for the Treatment of Women with Anterior/Apical Pelvic Organ Prolapse

Catherine Matthews, MD; Division of Urogynecology and Reconstructive Pelvic Surgery
Clinical Trial
Sponsor: Boston Scientific Corporation
Submitted: April 16, 2014

 

Uncovering the Genetic Susceptibility of Pelvic Organ Prolapse

Jennifer Wu, MD, MPH; Division of Urogynecology and Reconstructive Pelvic Surgery
RO1 Submission
Sponsor: NIH
Submitted: May 27, 2014